期刊
EXPERT REVIEW OF RESPIRATORY MEDICINE
卷 15, 期 5, 页码 609-621出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17476348.2021.1894133
关键词
Asthma; big data; data analytics; machine learning; statistics
资金
- MRC [MR/S025340/1] Funding Source: UKRI
Big data is reshaping the future of medicine, with a shift towards data-driven hypothesis-generating methods in asthma research. However, despite advancements, few findings have been translated into clinically actionable solutions. Embracing collaborative science and cross-disciplinary teams is necessary to fully capitalize on the potential of big data.
Introduction: Big data are reshaping the future of medicine. The growing availability and increasing complexity of data have favored the adoption of modern analytical and computational methodologies in every area of medicine. Over the past decades, asthma research has been characterized by a shift in the way studies are conducted and data are analyzed. Motivated by the assumptions that 'data will speak for themselves', hypothesis-driven approaches have been replaced by data-driven hypotheses-generating methods to explore hidden patterns and underlying mechanisms. However, even with all the advancement in technologies and the new important insight that we gained to understand and characterize asthma heterogeneity, very few research findings have been translated into clinically actionable solutions. Areas covered: To investigate some of the fundamental analytical approaches adopted in the current literature and appraise their impact and usefulness in medicine, we conducted a bibliometric analysis of big data analytics in asthma research in the past 50 years. Expert opinion: No single data source or methodology can uncover the complexity of human health and disease. To fully capitalize on the potential of 'big data', we will have to embrace the collaborative science and encourage the creation of integrated cross-disciplinary teams brought together around technological advances.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据